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Friend leukemia virus (FLV) 1 (1)  is a C-type murine retrovirus that induces rapid 
effects on erythropoiesis in susceptible mice (1-5). Like other acute leukemia viruses, 
FLV is a complex of two viruses, a replication-defective component(s) Friend spleen 
focus-forming virus  (SFFV)  (5)  and a  replication-competent virus, F-MuLV (4-7). 
Recent  studies  (8,  9)  using  molecularly cloned  SFFV  DNA  have  indicated  that 
erythroleukemia can  be  induced  by  F-MuLV  and  a  single  SFFV  genome.  The 
erythroleukemia induced by FLV can be divided into at least two stages: an early 
stage of rapid splenomegaly at 1-3 wk post-infection (1-5, 9) and a more "malignant" 
stage of 3 wk or over, during which tumorigenic erythroleukemic cell lines can be 
detected in  the infected spleens  (10-15).  Other hematological changes can also be 
recognized during the early phase of the disease. For example, the rapid splenomegaly 
is accompanied by extensive proliferation and differentiation of immature erythroid 
cells  and  the  appearance  of large  numbers  of cells  capable  of forming erythroid 
colonies (CFU-E) in vitro (16-18, 4). 
In addition to these hematological aberrations, a rapid change in the hematocrits 
of these mice can also be detected early in the disease (1, 2, 4). The direction of these 
changes, however, can be different in response to two distinct strains of FLV (1, 2, 4). 
After infection of the original Friend isolate of FLV  (1)  (FV-A),  the mice rapidly 
developed  anemia  at  2-3  wk  after  infection.  However,  a  distinct  strain  of FLV 
(FLV-P) was subsequently isolated by Mirand (2) that is capable of inducing a rapid 
and severe polycythemia instead of the anemia.  These contrasting changes  in  the 
hematocrits  of the  infected  mice  were  found  to  be  a  function  of the  defective 
components SFFVA and SFFVp, which are associated with FV-A and FV-P complexes, 
respectively (4,  5).  In addition to a  difference in hematocrits of the infected mice, 
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there is also a  difference in the response of the erythroid progenitors of these mice to 
the  hormone  erythropoietin  (epo)  (4,  16-18)  after  infection  by  FV-A  or  FV-P. 
Although erythroid progenitor cells in FV-A-infeeted mice require epo to proliferate 
(4,  19, 20), the erythroid progenitors detected in susceptible mice early after infection 
with FV-P are independent of epo (4,  16-18). 
In the present communication, we investigated the host contributions to these early 
changes in erythropoiesis. This study indicates that in addition to the viral contribu- 
tions, host genes also play an important role in determining the outcome of the early 
changes induced by FLV. In a preliminary report (21), we described the identification 
of a  host gene locus, Fv-5, that determines  the induction of early anemia or polycy- 
themia by FV-P. In this report, we confirmed these findings and extended the study 
to investigate the possible  modes of action of the locus.  It was determined  that  this 
locus, Fv-5, may control the level of erythrocytes by regulating the rates of proliferation 
of a  relatively  mature  (post  CFU-E)  erythroid  precursor  cell  in  the  spleens  of the 
mice. 
Materials  and Methods 
Mice.  Female  mice of strain CBA and  DBA/2, aged 6-10 wk,  were obtained  from The 
Jackson Laboratory, Bar Harbor, ME. 
Virus.  Clonal isolation of FV-P and FV-A was described elsewhere (4). SFFVA and SFFVp 
titers (FFUs) were determined by spleen focus-forming assay in DBA/2 mice (5). The F-MuLVp 
clone used  in  this study is an  NB-tropic clonal isolate obtained  after end-point  dilution  of 
FV-P (4, 6). Titers of F-MuLVp were determined by XC plaque assay and expressed in plaque- 
forming units (PFU)/ml (6, 22). 
Clones of RAT-I cells nonproduetively infected with SFFVA (PS)  (4) and SFFVp (501)  (4) 
virus were rescued by infection with F-MuLVp at a multiplicity of 0.1  PFU/cell  (6). Culture 
supernatants were harvested after the cells had been passaged by trypsinization and replating 
two or three times after infection. 
Molecularly cloned SFFVp DNA was obtained as previously described  (9). After calcium 
phosphate-mediated transfection of the SFFVp DNA fragment into NIH/3T3 cells, F-MuLVp 
was used to rescue the SFFVp components, and the culture fluid containing rescued virus was 
harvested and inoculated into DBA/2 or CBA mice (9). 
Culture of CFU-E or CFU from  Virus-infected Mice  (CFU-E*).  The assay for colony-forming 
unit erythroid (CFU-E or CFU-E*) was performed as described previously (23). In short, bone 
marrow cells were obtained by flushing femurs with t~-medium.  Spleen cell suspensions were 
made by pressing spleen fragments with glass slides.  After washing with a-medium, the bone 
marrow or spleen cells were plated in 1 ml of 0.8% methylcellulose in t~-medium supplemented 
with 7.5 x  10  -5 M  2-mercaptoethanol,  1% deionized bovine serum albumin (Sigma Chemical 
Co.,  St.  Louis,  MO),  and  30%  fetal  calf serum  (Flow  Laboratories  Inc.,  McLean,  VA). 
Erythropoietin  (lot  3038;  Connaught  Laboratory, Toronto,  Canada)  was  added  at  a  final 
concentration of 0.5 U or as specified.  Colonies containing 8-64 hemoglobinized cells at day 2 
were counted as CFU-E or CFU-E*. 
Colony Assay for Friend Virus-induced Tumorigenic Cells (CFU-FV).  The assay for CFU-FV was 
performed as described previously (13). Briefly, cells (1 ×  106 cells/ml) from individual spleens 
were cultured in  1.3% methylcellulose in Iscove's modified Dulbecco's medium (24) with 30% 
heat-inactivated fetal calf serum and 1 ×  10  -s M 2-mercaptoethanol. Dishes were incubated at 
37°C for 14 d, at which time macroscopic colonies (containing  104-105 cells)  were scored by 
eye. 
Assay ofHematocrit, E~ythrocytes, and Reticulocytes.  For hematocrit assays,  blood samples were 
taken  from tail  veins of the mice every week with heparinized  hematocrit  tubes  (American 
Dade Divison, American Hospital Supply Corp., Miami, FL). Erythrocytes (RBC) were counted 
with the aid of a hemocytometer, and reticulocytes in the peripheral blood, bone marrow, and 
spleen cell suspensions were stained with new methylene blue and counted at weekly intervals. 400  ERYTHROLEUKEMIA  INDUCTION  BY  FRIEND  LEUKEMIA  VIRUS 
Assays of Etythroblasts in the Bone Marrow and Spleens.  Bone  marrow  and  spleen  cells were 
suspended in phosphate-buffered saline (phosphate, 0.02 M, NaCl 0.14 M; pH 7.2) containing 
1%  bovine  serum  albumin  at  the  concentration  of  1  ×  10  e  cells/ml,  and  0.1  ml  of these 
suspensions were spun onto a  slide glass. After air drying, the cells were fixed with methanol 
and stained with Giemsa staining solution, and the number of erythroblasts was counted. 
Uptake ofn~Fe by the Bone Marrow and Spleens.  Mice were injected with 0.1/~Ci  of radioiron 
([59Fe]Clz) in 0.5 ml of phosphate-buffered saline. 6 h  after injection, the mice were killed. The 
spleens and femurs were removed, and radioactivity was assayed as described elsewhere (25). 
Data was expressed as percent of radioiron injected. 
Results 
Hematocrit  Changes in  DBA/2  and  CBA  Mice  after Infection  with  FV-P and  FV-A 
Preparations from  Different  Sources.  In  a  preliminary  communication  (21),  we  have 
shown that after infection of DBA/2 and CBA mice with FV-P, contrasting changes 
of hematocrits could be observed in these two strains of mouse. To ensure that these 
contrasting effects were induced by the SFFVp genome, FV-P stocks were obtained 
bya variety of methods. Results in Table I indicate that after infection of FV-P virus, 
a  severe  polycythemia  developed  in  DBA/2  mice,  whereas  a  rapid  anemia  was 
induced in the latter. This result confirms our preliminary report (21) that contrasting 
changes of hematocrit are induced in these two strains of mouse. Anemia was induced 
in both strains of mouse when FV-A virus w~  used. To ensure that the FV-P used 
was no~ contaminated with SFFVA, two rat cell clones,  P5  (4), nonproductively in- 
fected with SFFVA and 501  (4), nonproductively infected with SFFVp, were rescued 
with cloned F-MuLV,  and the resulting virus preparations were used.  Results  indi- 
cated again that anemia developed in CBA mice, whereas polycythemia developed in 
DBA/2  mice  when  SFFVp  was  rescued.  SFFVA  rescued  with  F-MuLV  induced 
TABLE  I 
Hematocrit Values of DBA/2 and CBA Mice 2 wk after Infection with FLV* 
Percent hematocrit 
DBA/2  CBA 
Uninfected 
FV-P* 
FV-A, 
F-MuLV:~ 
F-MuLV +  rat nonproducer 501  (SFFVp)* 
F-MuLV +  rat nonproducer P5 (SFFV^):~ 
F-MuLV +  NIH/3T3  ceils (Transfected with 
SFFVp DNA)§ 
Spleen extracts of CBA Mice (FV-P)H 
51.0:1:1.0  49.5 "4" 0.5 
66.5 :t: 0.9  36.8 :t: 3.7 
40.0 -4- 2.0  34.5 :t: 7.3 
47.3 :t: 1.5  47.5:1:3.5 
65.3:1:3.7  41.9 +  5.3 
45.0:1:1.6  39.3 :t: 1.5 
73.0 ±  0  30.0 :t: 5.9 
69.7  :t: 2.5  41.2:1:4.0 
* Virus preparations were injected into 6-10-wk-old DBA/2 or CBA mice through 
the tail veins. 2 wk after infection, the hematocrit values were determined. At least 
four mice were used in each determination. 
:1: Virus preparations of FV-P (2 ×  10  s FFU), FV-A (10 a FFU), F-MuLV (2.5  ×  106 
XC  plaque  units),  and  rat  nonproducer cell  clones 501  and  P5  were  described 
previously,  as  in  ref.  4.  Rescue  of the  nonproducer cell  clones  is  described  in 
Materials and Methods. 
§ Transfection of NIH/3T3 cells with molecularly cloned SFFVp DNA and rescue of 
the NIH/3T3 cells was described in ref. 9. 
II 6-wk-old mice were injected with FV-P (2 X  10  s FFU) (4). 2 wk later, the mice were 
killed and a  10% spleen extract was obtained from the spleens of these mice. The 
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anemia in both strains of mice. To further rule out the possibility of any SFFVA viral 
genomes in the SFFVp nonproducer cell clone 501, we transfected molecularly cloned 
SFFVp  DNA  into  NIH-313 cells  and  rescued  the  transfected  cells  with  cloned  F- 
MuLV  (9).  As can be seen in Table I, this virus preparation,  which  contains  only 
SFFVp and cloned F-MuLV, also induced anemia in CBA mice and polycythemia in 
DBA/2  mice (Table I). Finally,  there is the possibility that after infection of FV-P 
into CBA mice, certain host-induced changes in the SFFp viral genomes occurred, or 
perhaps endogenous  SFFVa-like  viruses  were  induced.  To  examine this  possiblity, 
spleen extracts of anemic CBA mice 2 wk after infection with FV-P were injected into 
DBA/2 and CBA mice. Results in Table I indicate that, similar to the original FV-P, 
this spleen extract was capable of inducing  a  severe polycythemia in  DBA/2  mice 
and a  rapid anemia in CBA mice. These results indicate that the induction of these 
contrasting  changes  in  hematocrits  in  DBA/2  and  CBA  mice is  a  function  of the 
SFFVp genome. 
Levels of Circulating Reticulocytes and RBC in CBA and DBA/2 Mice after Infection with 
FV-P and FV-A.  The  kinetics  of changes  in  the  levels of mature  erythroid  cells, 
retieulocytes, and RBC in the peripheral blood of these mice were examined. DBA/2 
and CBA mice were infected with FV-P, and the levels of reticulocytes and RBC were 
measured at different intervals after infection.  Results showing the average numbers 
of reticulocytes  and  RBC  are  illustrated  in  Fig.  1.  The  data  indicate  that  after 
infection  with  FV-P,  there  was  an  increase  in  the  levels of RBC  in  the  blood  of 
DBA/2 mice and a corresponding decrease in the level in the blood of the CBA mice, 
accounting  for the  differences in  the  observed  hematocrits  in  these  infected  mice. 
Examination  of the  levels of reticulocytes  in  the  blood of these  infected  mice also 
revealed similar changes, with a  rise in the reticulocyte levels in DBA/2 mice and a 
drop in reticulocytes in the CBA mice during the first 2 wk. Results of experiments 
after the kinetics of changes in RBC and reticulocytes levels in the individual infected 
DBA/2 or CBA mice also revealed similar patterns of changes (Fig.  1 b). Subsequent 
to infection of FV-A, however, the level of RBC decreased in both CBA and DBA/2 
mice, accounting for the reduction of hematocrits in these mice (Fig. 2). Changes in 
the levels of reticulocytes in these FV-A-infected mice was similar to those of FV-P- 
infected mice, although  the number of reticulocytes in FV-A-infected DBA/2  mice 
did not increase to the same level as those in FV-P-infected animals. 
E~ythroid Progenitor Colonies (CFU-E) in DBA/2 and CBA Mice Infected and Uninfected 
with FV-P.  It is possible that these differences in erythropoiesis might be the reason 
for  the  changes  in  hematocrit  levels  in  these  infected  mice.  These  studies  were 
performed !n DBA/2 and BALB/c mice. To examine whether there are differences in 
erythropoletm requirement of the CFU-E* in DBA/2 and CBA mice, we examined 
the epo requirements of the CFU-E formation in infected and uninfected CBA and 
DBA/2 mice. Results of these investigations are illustrated in Figs. 3 and 4. Although 
there was a  slight difference in the number of CFU-E in the absence of any added 
epo,  the  epo ~ose-response curves were essentially the same  for.the  CFU-E  in  the 
uninfected  DBA/2  and  CBA  mice.  Without  any  added  epo,  ~20  CFU-E  per  105 
nucleated  cells could be detected  in CBA mice, whereas no detectable CFU-E was 
found in  DBA/2  mice in the absence of any added hormone. However, other than 
this small difference, the epo dose-response curves for the CFU-E in both strains of 
mice were very similar, reaching a  maximum of ~200-250 colonies/105 cells at ~0.2 402  ERYTHROLEUKEMIA INDUCTION BY  FRIEND  LEUKEMIA VIRUS 
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Fio.  1.  Kinetics of change in the levels of reticulocytes  and RBC in the peripheral blood of CBA 
and DBA/2 mice infected with FV-P. CBA and DBA/2 mice were infected with 2 x  103 FFU of 
FV-P. At various times after infection,  the levels of reticulocytes  or RBC were determined in the 
peripheral blood of these cells. Data from two separate experiments are illustrated.  The results from 
panel b shows kinetic changes of individual mice. Q, DBA/2 mice; (D, CBA mice. 
U/plate.  We  next  examined  the  epo  dependence  of CFU-E*  formation  in  the  two 
strains of mouse infected with FV-P.  Equal doses of FV-P were injected into CBA or 
DBA/2  mice, and  the  levels of CFU-E  in  the spleens  and  marrow  of these  animals 
were  measured  in  the  presence  or absence  of 0.5  U/plate  of epo  at  0,  1,  2,  or  3  wk 
after infection. Results are illustrated in Fig. 4. The data in Fig. 4 a  showed all of the I0 
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FIG. 2. (left).  Kinetics of change in the level of reticulocytes and RBC in the peripheral blood of 
CBA and DBA/2 mice infected with FV-A. Same as Fig. 1, except 108 FFU of FV-A was used. O, 
DBA/2 mice; O, CBA mice. 
Fro. 3. (right).  Dose-response curves ofepo in the formation of CFU-E in marrow cells from CBA 
and DBA/2 mice. Bone marrow cells were obtained from 6-wk-old CBA or DBA/2 mice and plated 
for CFU-E in the absence or presence of different concentrations of epo, as described in Materials 
and Methods. Q, DBA/2 mice; O, CBA mice. 
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CFU-E*  in the spleens of these animals were under the control of epo at the time of 
infection.  This  was  then  followed  by  a  dramatic  increase  in  the  number  of epo- 
independent erythroid colonies as early as  1 wk post-infection in both mouse strains. 
Results from the bone marrow of these infected animals are summarized in Fig. 2 b. 
The data showed that at the time of infection there was also CFU-E* in these animals, 
and all of these colonies from the DBA/2 mice and most of those from the CBA mice 
are epo dependent. At  1 wk after infection by FV-P, however, there was an increase 
in the number of epo-independent colonies in the marrows of both strains of mouse. 
This was then followed by a  further increase in the number of CFU-E* colonies in the 
2nd  and  3rd wk after infection.  Similar results were obtained in three independent 
experiments.  These  results  showed  that  like  the  DBA/2  mice,  there  was  also  a 
significant increase in the levels of epo-independent CFU-E*  in the CBA mice after 
infection with FV-P, indicating that the proportion of erythropoiesis under the control 
of epo after infection by FV-P was not responsible for the contrasting effects on the 
levels of RBC in the peripheral blood of these animals. 
Pathology  of  Friend  Disease  in  CBA  and  DBA/2  Mice  Early  after  Infection  with 
FV-P.  We next  examined the pathology of the Friend disease in CBA mice early 
after  infection  with  FV-P.  This  was  compared  to  the  effects  in  the  DBA/2  mice. 404  ERYTHROLEUKEMIA  INDUCTION BY  FRIEND LEUKEMIA VIRUS 
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FIG. 4.  Kinetics of change in CFU-E levels with or without added epo in the spleen and marrow 
of CBA and DBA/2 mice after infection of FV-P. 2 X 10  a FFU of FV-P was injected into CBA or 
DBA/2 mice. At various times after infection, the number of CFU-E was measured in the spleens 
(a) or marrow (b) cells from these mice. O, DBA/2 with 0.5 units of epo mice; C), CBA mice with 
0.5 units of epo; V, DBA/2 mice without epo; V, CBA mice without epo. 
2 ×  10  a FFU of FV-P were injected into CBA and DBA/2 mice, and the kinetics and 
extent of splenomegaly were examined.  Results in Fig. 5  showed that  similar to the 
DBA/2 mice, a  rapid splenomegaly was induced in CBA mice by FV-P. The extent 
of the splenomegaly in the CBA mice, however, was not as severe as in DBA/2 mice. 
Although the spleen weights of the DBA/2 mice reached a  plateau of ~2-2.5 g, those 
of the CIBA mice reached  a  maximum  of ~1-1.5  g, one-half the size of the DBA/2 
spleens. 
The morphology of the cells in these enlarged spleens of CBA mice and DBA/2 
mice were examined and compared. The cells from the spleens of both strains of mice 
were  similar in  morphology and  included  a  large proportion  of erythroblasts. The 
kinetics  of changes  in  the  proportion  of erythroblasts  was  also  monitored  in  the 
marrow and spleens of these DBA/2 and CBA mice. Fig. 6  shows the results of one 
such experiment. The percentage of erythroblasts decreased in the marrow 2 wk after 
infection before increasing at 3 wk (Fig. 6, upper panel). In contrast to these relatively 
small changes in the marrow, the erythroblasts increased dramatically in the spleens 
of these mice from ~10% to -80-90%  in 3 wk (Fig. 6, lower panel). 
Erythroleukemia induction in susceptible mice by FV-A and FV-P is known to be 
associated with  splenomegaly and changes  in hematocrit  values. These changes are 
probably related to the high  mortality rate in these mice. To examine whether  the 
erythroleukemias  induced  in  CBA  and  DBA/2  mice  are  associated  with  different 
mortality rates after infection, 2 ×  10  a FFU of FV-P or FV-A were injected into CIBA 
or DBA/2 mice, and the survival of these mice was monitored at 4 wk after infection. 
Results of these experiments are shown in Table II. The data indicate that significant 
differences in the mortality rates of these mice after infection with FV-A and FV-P TSUNEFUMI SHIBUYA, YOSHIYUKI NIHO, AND TAK W.  MAK 
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FIG.  5.  Kinetics of change in spleen weights of CBA and DBA/2 mice after infection with FV-P. 
2 × 10  a FFU were injected into each CBA or DBA/2 mice. At various times after infection, the mice 
were killed and the spleen weights were determined. 0, DBA/2 mice; O, CBA. 
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can  be  detected.  The rates  of mortality was  higher  in  DBA/2  mice infected with 
FV-P and in CBA mice infected with FV-A. 
Tumorigenic Colonies in  CBA  Mice  Infected with  FV-P.  Recent  results  (13)  have 
indicated that newly developed tumorigenic erythroid colonies (CFU-FV) capable of 
extensive proliferation can be detected in the spleen of DBA/2 mice late after infection 
with FLV. These in vitro colonies can be found in the spleens of these DBA/2 mice 
3-6 wk after infection with FV-P and 10-12 wk after infection with FV-A (13,  15). To 
examine whether these tumorigenic cells  can also be detected in CBA mice infected 
with FV-P and the relative rate of emergence of the CFU-FV, cells from spleens of 
CBA mice infected with FV-P were plated for CFU-FV 4-6 wk after infection. Results 
in Table III indicate that, similar to DBA/2 mice, tumorigenic cells,  as detected by 
this assay, can also be found in the spleens of the CBA-infected mice. Furthermore, 
these colonies were detected at 4-6 wk after infection, indicating that the kinetics of 
emergence are similar to those in FV-P-infected DBA/2 mice. 
Levels of Reticulogytes and in the Marrow and Spleens of DBA / 2 and CBA Mice Infected with 
FV-P.  The differences in the levels of RBC and reticulocytes in the peripheral blood 
of these infected mice (Fig.  1) could reflect the rates oferythropoiesis in their respective 
marrow and/or the spleens. The data presented above indicated that at the level of 
CFU-E*  (Fig.  4)  and erythroblasts  (Fig.  6), the magnitudes and rates of increase of 
these progenitor cells  were the same in  the spleens  and marrows of both strains of 
mice after infection with FV-P. The kinetics of changes of levels  of reticulocytes in 
marrow and spleens were next examined.  Results are illustrated  in Fig.  7 a  and  7 b. 
The data showed that there were rapid decreases in the percentages of reticulocytes 
in the marrows of both strains of mice from ~70-75%  to ~20-25%  after 2 or 3 wk 406  ERYTHROLEUKEMIA  INDUCTION  BY  FRIEND  LEUKEMIA VIRUS 
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FIG. 6.  Kinetics of change in the percent of erythroblasts in the marrow and spleens of CBA and 
DBA/2 mice infected with FV-P. 2 X 10  s FFU were injected into each CBA or DBA/2 mice. At 
various times the mice were killed and the percent of erythroblasts was determined in the marrow 
(a) or spleens C  o) of these mice. 0, DBA/2 mice; ©, CBA mice. 
TABLE II 
Early Mortality of CBA and DBA/2 Mice Infected with FV-P or FV-A* 
Number of mice that died 4 wk after infection 
FV-P  FV-A 
DBA/2  53% (2/5; 3/5; 3/4; 2/5)  0% (0/5; 0/5; 0/4) 
CBA  12% (1/4; 0/5; 1/4; 0/4; 0/4)  43% (2/5; 3/5; 2/6) 
* CBA or DBA/2 mice were infected with 2 × 10  s FFU of FV-P or FV-A. 4 wk 
after infection,  the mortality of these infected mice was determined. Numbers 
in parentheses represent separate experiments. 
(Fig. 7 a). A difference in the percentage of reticulocytes in the spleens of DBA/2 and 
CBA  mice,  however,  could  be  observed  after  infection with  FV-P.  Although  the 
percentage of reticulocytes in the spleen of the infected CBA mice remained relatively 
constant at  ~10%  for 2  wk and then increased slightly to -20%, the percentage of 
reticulocytes in the spleens of DBA/2 mice rose dramatically to a  level of ~50% 2 wk 
after infection (Fig. 7 b). Similar results were obtained in three separate experiments. 
This dramatic rate of increase in reticulocytes in DBA/2 mice with little change in 
the CBA mice reflects a higher rate of erythropoiesis in the spleens of the DBA/2 mice 
and might explain the difference in hematocrit values observed in these two strains of 
mouse. 
Rate of Uptake of Radioiron in Femur and Spleens of DBA/2 and CBA Mice after Infection 
with FV-P.  The rates of erythropoiesis as measured by uptake of 59Fe in the femurs TSUNEFUMI  SHIBUYA, YOSHIYUKI NIHO,  AND TAK W.  MAK  407 
TABLE III 
Detection of Tumorigenic Colonies (CFU-FV) in CBA and DBA/2 Mice 
Early and Late after Infection with FV-P* 
Number of tumorigenic colonies (per 
5 X  10  6 spleen cells) 
4-6 wk  10-12 wk 
CBA mice infected with FV-P  12, 56  All mice died 
DBA/2 mice infected with FV-P  62, 161  All mice died 
DBA/2 mice infected with FV-A  0, 0  6, 82 
* CBA or DBA mice were injected with 2 X 103 FFU each of FV-P. 4-6 wk or 
10-12 wk after infection, the mice were killed, and the spleen cells were 
plated  for CFU-FV, as described in Materials and Methods. FV-A were 
injected into DBA/2 mice  as controls. 
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FIG.  7.  Kinetics of change in the level of reticulocytes in the marrow (a) and spleens (b) of CBA 
or DBA/2 mice infected with FV-P. Same as Fig. 6, except reticulocytes were determined. O, 
DBA/2 mice; Q, CBA mice. 
and spleens of DBA/2 and CBA mice after infection of FV-P were also examined. At 
various times after infection with  FV-P, SaFe  in the  form of [59Fe]Cln  was  injected 
intravenously into these mice, and the uptake into the femurs and spleens of these 
mice was  measured and expressed  as  the  percentage of SgFe injected. Results from 
these experiments are illustrated in Fig. 8 a  and 8 b. The data showed that similar to 
the decrease in reticulocyte levels, a  rapid drop  in the rate of iron uptake was also 
detected in the bone marrows of the DBA/2 or CBA mice. In contrast, an increase in 
the  rate  of iron  uptake  was  detected  in  the  spleens  of both  strains of mouse.  In 
addition, a significant difference in the rate of uptake was observed in the two strains 
of mice. While the rate of uptake of 5SFe in the spleens of CBA mice was ~ 15%,  the 
rate  of uptake  in  the  DBA/2  mice  rose  to  20%.  These  results  support  the  above 
observation that there is a  decrease in the level of erythropoiesis in the marrow and 408  ERYTHROLEUKEMIA INDUCTION BY  FRIEND  LEUKEMIA VIRUS 
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FIG. 8.  Rate of iron uptake in marrow and spleens of CBA or DBA/2 mice infected with FV-P. 2 
x  l0  a FFU of FV-P were injected into CBA or DBA/2 mice, and, at various times after infection, 
[SaFe]Cla was injected into these mice, and the rate of uptake of ~Fe in the femurs (a) or spleens (b) 
was determined, as described in Materials and Methods,  and expressed as percent of SSFe injected. 
O, DBA/2 mice; O, CBA mice. 
an  increase in  the level of erythropoiesis in  the spleens of these mice shortly after 
infection  with  FV-P.  Furthermore,  the  rate  of erythropoiesis  was  higher  in  the 
DBA/2 mice. 
Discussion 
The pathological outcome after leukemia virus infection and transformation is the 
result of a complex array of interactions between viral genomes and the host. These 
developments occur at  two levels, the cellular and  the physiological. Effects at  the 
latter level can be influenced by developments at the former. Examples of such viral- 
host interactions are probably best  illustrated in  the Friend leukemia virus  (FLV) 
system, where a number of host genes are known to control the susceptibility of the 
host-to-FLV infections (26-32). The results presented in this communication indicate 
that, in addition  to controlling the susceptibility, host  genes are also  important  in 
determining the type of erythropoiesis induced by the FLV. 
Much information is now available about the contributions made by the FLV viral 
genomes. Subsequent to infection by FLV complexes or F-MuLV, rapid changes in 
erythropoiesis can  be  detected.  Concomitant  with  the  splenomegaly, a  rapid  and 
dramatic  elevation  in  the  number  of erythroid  progenitor  cells  CFU-E*  can  be 
detected after infection of the FLV complexes (4,  16-18). After infection of newborn 
BALB/c mice by the helper-independent F-MuLV, however, a  dramatic increase in 
the more immature erythroid progenitor bursts (BFU-E*) was observed instead of the 
increased CFU-E after FLV infection (33). These differences in erythropoietic response TSUNEFUMI SHIBUYA, YOSHIYUKI NIHO, AND TAK W.  MAK  409 
are  controlled  by  the  viral  determinants  on  the  SFFV  and  F-MuLV  genomes. 
Determinants within the two SFFV genomes  (SFFVA and  SFFVp)  have also been 
shown to be responsible for the differences in the erythroid populations in FV-A- and 
FV-P-infected mice. For example, erythroid colony-forming cells (CFU-E*) detected 
in susceptible mice early after infection with pseudo-types of SFFVp are independent 
of the hormone erythropoietin (16-18), whereas erythroid progenitor cells in SFFVA- 
infected mice still require epo to proliferate (4,  19, 20). 
After  infection with  FV-A,  rapid  anemia  develops  in  the  mice,  whereas  severe 
polycythemia is induced after infection with FV-P (1-5). The exact reason(s) for these 
contrasting physiological effects is not known. It is possible that the differences in the 
levels of RBC is accounted for by the nature of the epo-dependent and epo-independ- 
ent erythropoiesis induced by the FV-A and FV-P, respectively. On the other hand, 
a  variety  of other  effects,  including  the  rates  of hemolysis  or  cytolysis,  rates  of 
proliferation, or differentiation of the infected and transformed cells in the marrow 
and spleens of these animals, as well as the rates of transport of these erythroid cells 
to the blood, might also contribute to the final value of hematocrit. A study of these 
physiological changes after the infection of FV-A or FV-P has been described (34). It 
was suggested that the reasons behind the induction of polycythemia by FV-P and 
anemia by FV-A in the same strain of mouse might have been due to the increased 
rate oferythropoiesis after infection by FV-P and the expansion of blood volume after 
FV-A infection. 
Data  in  this paper indicate that  host  genes are indeed involved in affecting the 
types  of pathological  changes  in  these  FLV-infected mice.  Unlike  the  host  genes 
described before, which are known only to determine the susceptibility to infection by 
FLV  (26-32), the host determinant(s)  identified in this study controls the types of 
physiological alteration induced by the FLV complexes. A  locus whose phenotypes 
segregate in a co-dominant nature in determining whether rapid anemia or polycy- 
themia is induced in mice early after infection with FV-P has been identified (21), 
and it was proposed that this locus in the mouse be termed Fv-5 (21). Mouse strains 
that develop anemia early after infection with FV-P have genotypes Fv-5  a', whereas 
mouse strains with severe polycythemia have genotypes Fv-5  pp. 
It has been established that Friend virus-induced erythroleukemia is a  multistage 
disease (10-15) with well-defined early erythropoietic changes (1-5,  16-18) and late 
stages during which tumorigenic cell clones emerge (10-15). However, in addition to 
responding with  different hematocrit values,  mice infected with  FV-A or FV-P or 
newborn mice infected with F-MuLV also respond differently with respect to some of 
these early and late changes  (4,  33). The data in this communication indicate that 
although anemia is elicited, the early and late cellular aspects of the disease in Fv-5 aa 
mice infected with FV-P are similar to those in Fv-5  eP mice that develop polycythemia 
(16-18). First, like those of the FV-P-infected Fv-5  ~'P mice, a dramatic increase in epo- 
independent erythroid progenitor cells, CFU-E*, was observed. Second, similar to the 
DBA/2 mice infected with FV-P, the CBA mice injected with FV-P also developed 
tumorigenic cell clones, as detected by the Friend-transformed cell colony assay (CFU- 
FV)  (13,  14). In addition, the CFU-FV emerged at relatively early time (before 4-6 
wk after infection), as compared with a minimum of 10 wk required for FV-A-infected 
mice  (13)  or  the prolonged period  (>15  wk)  with  RBC  transfusion  for F-MuLV- 
infected newborn mice (35, 36). From these cellular properties, it would appear that 410  ERYTHROLEUKEMIA  INDUCTION BY FRIEND LEUKEMIA VIRUS 
the FV-P-injected CBA  mice resemble the  FV-P-infected Fv-5  PP mice rather than 
FV-A- or F-MuLV-infected mice. The development of anemia in these FV-P-infected 
Fv-5  °~  animals  might  thus  be  the  result  of some  other  cellular  or  physiological 
functions. 
In  the  experiments described  in  this  communication, cellular and  physiological 
alterations  were  examined.  As  would  be  expected,  different  levels  of RBC  and 
reticulocytes in the blood of the DBA/2 and CBA mice were observed, accounting for 
the contrasting changes in the hematocrits in the two strains of mouse. In the marrows 
of both strains of mice, a  reduction of erythroblasts was noted early after infection. 
This  was  also  accompanied  by  moderate  increases  in  epo-independent  CFU-E*, 
decrease in the levels of reticulocytes, and a reduction in the rate of hemoglobinization 
as measured by 5aFe uptake. These viral-induced alterations, however, were similar in 
both strains of mice and thus cannot explain the differences in observed hematocrit 
values. Unlike the changes in the marrows, significant differences in erythropoietic 
activity were observed in the spleens of these two strains of mice. While the spleens of 
both strains of mouse contained about the same level of CFU-E* and erythroblasts, 
the proportion of reticulocytes in the spleens increased dramatically in DBA/2 mice 
to ~50%, while the reticulocyte level in the spleens of CBA mice remained unchanged 
at ~ 10-20%. In addition, the rate of erythropoiesis as measured by 59Fe uptake also 
increased to a significantly higher level in DBA/2 mice. This higher rate of erythro- 
poiesis combined with a more severe splenomegaly (2.5 g per DBA/2 spleen compared 
with ~ 1.25 g per CBA spleen)  in the DBA/2 mice would result in a  higher rate of 
production of RBC, accounting for the severe polycythemia. Thus, it would appear 
that the Fv-5 locus might control the rate of proliferation of the erythroid precursors 
in the spleens of these infected animals. At the present time, it is not known which 
erythroid precursor cell or cells is controlled by this newly identified locus. However, 
because the levels of erythroid progenitor cell CFU-E* were similar in the two strains 
of mice, the cell or cells affected is probably more mature than CFU-E. 
The identification of Fv-5 adds another locus to a  long list of host genes that are 
known  to  affect FLV-induced erythroleukemia and  another mechanism  by which 
these host genes affect the disease. Some of these genes, such as the Steel (37, 38),  W 
(38, 39), f  loci  (40), and  the H-2 complex (41), are involved in controlling normal 
differentiation and developments. The best studied of this group is the Steel locus. It 
was determined (42)  that this locus, which is known to prohibit the development of 
the hemopoietie stem cell, CFU-S (36), may also act by inhibiting the proliferation of 
the early transformed cells.  The action of this locus, however, is specific for the early 
cells, as the late stage tumorigenic cells are immune from the control (12). The action 
of the other host determinants in the control of susceptibility to FLV is not so clear, 
although it is possible that the H-2 complex may affect the disease via immune system 
(30) or by control of the expression of SFFV-specific sequences (27). 
Of the other loci, Fv-1 (43), Fv-2 (29), and Fv-4 (44), much is also known about the 
actions of the first two. Fv-1 acts by inhibiting the replication of the helper F-MuLV, 
probably by controlling the integration of the provirus (45, 46). The Fv-2 locus, on 
the other hand, affects the SFFV component and may act by inhibiting the expression 
of SFFV-specific sequences (27, 47). However, although it might appear that the Fv- 
2  locus  acts  on  the  control or expression  of viral  sequences,  it  may  only prevent 
infection of SFFV  by controlling the  rate  of proliferation of the  erythroid burst- TSUNEFUMI SHIBUYA, YOSHIYUKI NIHO, AND TAK W.  MAK  411 
forming ceils BFU-E (48). Thus, it is possible that the Fv-2 locus and the Fv-5 locus 
may both affect the Friend disease by controlling the rates of proliferation oferythroid 
precursor cells.  In  the case of the F-2 locus, controlling the  cycling of the  earlier 
erythroid cells, BFU-E, could determine the susceptibility, as BFU-E might be the 
target  cell  (48).  On  the  other  hand,  control  of the  proliferation  of more  mature 
erythroid cells as in Fv-5 might only determine the severity of the disease as infection 
is established in a less mature erythroid cell. Thus, the higher rate of proliferation of 
the infected cells in the Fv-5  PP mice may affect only the type of erythropoiesis and the 
mortalities of these mice, but not susceptibility to infection by the virus. 
Summary 
This report confirms that the Fv-5 locus controls the types of erythropoiesis induced 
by Friend erythroleukemia virus (FLV) (21) and extends the study to investigate the 
mode of action of this locus. With the use of FLV obtained by a variety of procedures, 
we  showed  that  the  polycythemia spleen  focus-forming component  (SFFVp)  was 
responsible for the contrasting changes of hematocrits observed in FV-Pp (polycythe- 
mia strain)-infeeted DBA/2 (Fv-3  pp) or CBA (Fv-5  ~') mice. These changes in hema- 
tocrits were found to be a  direct result of the rise in  circulating reticulocytes and 
erythrocytes in DBA/2 mice and a corresponding drop of these erythroid cells in CBA 
mice 2 wk after infection. Examination of  the FV-P-induced cellular changes indicated 
that  dramatic  increase  in  erythropoietin  (epo)-independent  erythroid  precursor 
(CFU-E*) cells was detected in the spleens and marrow of both strains of mice. The 
epo  responsiveness of the  CFU-E  in  the  uninfected and  FV-P-infected CBA  and 
DBA/2 mice was also very similar. Similar to FLV-infected DBA/2 mice, the FV-P- 
infected CBA mice also developed tumorogenic cells (CFU-FV) relatively early after 
infection  (4-6  wk).  Study  of the  physiological  and  pathological  changes  in  the 
marrows and spleens of these infected mice indicated that significant differences were 
found in the spleens of the two strains of mice. The percent of reticulocytes in the 
spleen cells of CBA mice remained between 10 and 20%, and level of the DBA/2 mice 
increased  to  -50%.  This  higher  rate  of erythropoiesis  was  also  reflected  in  the 
significantly higher rate of uptake of SaFe in the spleens of the DBA/2 mice. These 
results suggest that the Fv-5 locus might control the hematocrit levels of these mice by 
regulating the rates of erythropoiesis in the spleen levels of these mice, probably by 
affecting the rate of proliferation of an erythroid cell or cells. The erythroid cell(s) 
affected is  likely to be more mature than the erythroid progenitor, CFU-E,  as  the 
levels of CFU-E in these two strains of mice were similar. The hypothesis that Fv-5 
may control the rates of proliferation of a  late erythroid (cell(s)  is also supported by 
the significantly higher spleen weights found in the infected DBA/2 (-2.5 g/spleen) 
mice than in the CBA (-1 g/spleen) strain. 
We thank Dr. Allan Howatson for comments on the manuscript. 
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